Trials / Terminated
TerminatedNCT04001179
Exploratory Metabolomics Study of Exhaled Breath in Pulmonary Embolism
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Pulmonary embolism is a frequent and recurrent pathology, especially in the elderly. It is often preventable, with high mortality and morbidity, making it a major public health issue. The clinical presentation of pulmonary embolism is non-specific and very highly variable, ranging from asymptomatic thrombus diagnosed incidentally to sudden death. The current diagnosis of pulmonary embolism is based on several diagnostic techniques, mainly non-invasive, which should be used sequentially. We propose to sample the volatile organic compounds using a device that allows them to be trapped on polymer cartridges. Sampling will be performed under monitoring of respiratory pressure and a capnograph to collect alveolar and upper respiratory tract air separately without contamination of the oral cavity or sinuses. This exploratory metabolic analysis will be non-targeted (analysis of all molecules detectable without a priori). The main objective of the study is to identify specific metabolic profiles to predict the results of ventilation-perfusion pulmonary tomoscintigraphy in subjects undergoing this examination for suspected acute pulmonary embolism. Secondary purposes : * To identify metabolic profiles to be used to predict, in combination with clinical probability scores, the results of ventilation-perfusion pulmonary tomoscintigraphy in subjects undergoing this examination for suspected acute pulmonary embolism.; * To correlate metabolic profiles with the topography of embolized lung territories
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pulmonary embolism diagnosis by nuclear medicine imaging | nuclear medicine imaging |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2021-12-01
- Completion
- 2024-01-15
- First posted
- 2019-06-27
- Last updated
- 2024-08-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04001179. Inclusion in this directory is not an endorsement.